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Background: Malaria mortality is mainly a direct consequence of inadequate and/or delayed diagnosis and case
management. Some important control interventions (e.g. long-lasting insecticidal nests) have contributed to reduce
malaria morbidity and mortality in different parts of the world. Moreover, the development and effective use of
rapid diagnostic tests (RDTs) hold promise to further enhance the control and elimination of malaria, particularly in
areas where health services are deficient. The aim of this study was to determine knowledge, attitudes, practices
and beliefs in relation to RDTs for malaria in rural Côte d’Ivoire.
Methods: One hundred individuals from Bozi and Yoho who sought care at the health centre in Bozi and were
offered an RDT for malaria were interviewed in April 2010 using a pre-tested questionnaire on practice and
perceptions in relation to RDTs for malaria. The relationships between acceptance of RDTs and factors related to
opinions were identified, using generalized linear mixed models. Qualitative data from open-ended questions
complemented the quantitative analysis.
Results: Only 34 out of 100 patients who were offered an RDT for malaria were willing to undergo the test. People
who perceived blood as a sacred body fluid were less likely to comply with an RDT. The concurrent availability and
use of RDTs for HIV and malaria was associated with an unwilling attitude towards RDTs for malaria (Fisher’s exact
test, p <0.001). The initial willingness of patients to accept malaria testing with RDTs was significantly related to
general fear and wanting to know malaria infection status. For further and regular use of RDTs, a strong relationship
was observed between acceptance and the idea that an RDT is a pretext used by health worker to know HIV status
(odds ratio (OR) = 16.61, 95% confidence interval (CI) = 1.03-268.5). Those thinking that blood samples were useful
for medical diagnoses were 8.31-times (95% CI = 2.22-31.1) more likely to undergo an RDT compared to those
rejecting blood sampling as a diagnostic strategy.
Conclusion: Socio-cultural factors might be barriers for accepting RDTs in general health services. There are social
representations of malaria and HIV/AIDS, symbolic for blood or experiences in relation to blood taking and
blood-related diseases in relation to the introduction and routine use of RDTs. Special attention should be given to
these barriers as otherwise the promotion of RDTs for prompt and effective diagnosis and subsequent
management of malaria is hampered.
Keywords: Malaria, Rapid diagnostic test, Blood, Blood-related disease, Social representation, HIV, Côte d’Ivoire* Correspondence: g.b.koudou@liverpool.ac.uk
†Equal contributors
1Département Environnement et Santé, Centre Suisse de Recherches
Scientifiques en Côte d’Ivoire, Abidjan, Côte d’Ivoire
3Laboratoire de Cytologie et de Biologie Animales, Unité de Formation et de
Recherche Sciences de la Nature, Université Niangui Abrogoua, Abidjan, Côte
d’Ivoire
Full list of author information is available at the end of the article
© 2012 Comoé et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Comoé et al. BMC Public Health 2012, 12:1089 Page 2 of 9
http://www.biomedcentral.com/1471-2458/12/1089Background
Malaria is still an important public health problem in
sub-Saharan Africa and elsewhere in the developing
world [1]. Children under the age of five years and preg-
nant women are the most vulnerable groups [2]. Mor-
bidity and mortality resulting from this parasitic disease
remain serious obstacles for the social and economic de-
velopment of the most affected regions [3,4]. Prevention
and control emphasising the use of long-lasting insecti-
cidal nets [5,6], indoor residual spraying [7] and prompt
diagnosis and adequate management of uncomplicated
malaria [8], have significantly reduced morbidity and mor-
tality in many endemic areas of Africa [9-11]. However,
primarily in remote rural areas, malaria remains a major
public health issue due to inadequate care [12] and the ab-
sence of effective diagnosis and treatment [13]. Although
symptomatic diagnosis has been successfully performed in
some remote areas [14,15], in high transmission settings,
it has often proven problematic [16-18] leading to an over-
use of antimalarial drugs. Usually, patients who present
with fever at a health facility are given artemisinin-based
combination therapies (ACTs) [19,20] without prior para-
sitological diagnosis [21,22].
Rapid diagnostic tests (RDTs) for malaria provide an
opportunity for improved point-of-care diagnosis and
better disease management in malaria-endemic areas
[23]. RDTs for malaria, similar to RDTs used to detect
the human immunodeficiency virus (HIV), can be uti-
lized at the point-of-care. RDTs are easy to use and
provide reliable results within 15–20 minutes [24,25].
Compared to other diagnostic methods (e.g. Giemsa-
stained thick and thin blood films examined under a
microscope), RDTs are highly cost-effective [26-28].
Consequently, RDTs have become essential tools in mal-
aria control and elimination [20,29-31].
Although several studies have been carried out to
investigate the diagnostic performance (i.e. sensitivity,
specificity and predictive values) of RDTs for malaria
[32-35], including willingness to pay for such tests [28],
there is a paucity of community-based studies investigat-
ing the acceptability and appropriateness of RDTs in re-
lation to people’s beliefs and practices. The purpose of
this study was to determine the knowledge, attitudes,
practices and beliefs of two rural communities in central
Côte d’Ivoire with regard to RDTs for malaria.Methods
Ethical considerations
The study protocol was reviewed by the institutional re-
search commission of the Centre Suisse de Recherches
Scientifiques en Côte d’Ivoire (CSRS; Abidjan, Côte
d’Ivoire) and received formal approval by the national eth-
ics committee of Côte d’Ivoire. The heads of householdsin the study villages were informed about the objective
and procedures of the study.
Oral consent was obtained from each patient (or legal
guardian/caretaker for minors) before using an RDT per-
formed on a finger-prick blood sample. Illiteracy rate is
very high in the study area leading to an oral rather than
written informed consent. The aims, procedures and data
confidentiality were explained to the participants, so that
they could make an informed decision of whether or not
they wanted to be enrolled. Participation was voluntary
with no further obligations for those who declined having
an RDT performed. All patients were offered free treat-
ment according to the diagnoses and the national treat-
ment guidelines.
Study area and population
The study was carried out in the Bozi health centre
located in the district of Bouaflé in central Côte d’Ivoire
(geographical coordinates: 06°55.151’ N latitude, 05°
32.080’ W longitude). This health centre serves mainly
two villages, Bozi itself and the neighbouring village
Yoho. The two villages are situated along the Bandama
River. The mean annual rainfall is approximately 1,000 mm
and the average temperature is about 27°C. At the time
of our study, there were 1,847 inhabitants in Bozi and
1,989 in Yoho [36]. Bozi people belong to the Baoulé
ethnic group, whereas Yoho people are Yowèrè.
The health centre in Bozi had been established in 1975
by a private donor, and is currently managed by a nurse
and a midwife. Two medical assistants complement the
health staff. Medical consultations are provided on a
daily basis and there are a few hospital beds available for
in-patients. Moreover, the Bozi health centre is used for
vaccinations of newborns and antenatal consultations.
For many years, patients visiting the Bozi health centre
received free treatment, including antimalarial drugs,
facilitated by regular provision of subsidized supplies by
the external grantee. The only financial contribution
requested by those who sought health care pertained to
drugs prescribed by the medical staff that were not avail-
able in the pharmacy of the Bozi health centre. From
1994 onwards, a payment scheme was established for
any services received by patients visiting Bozi health
centre due to the termination of external funds. This
change of policy from free treatment to a paying scheme
resulted in a substantial reduction of health service util-
isation. At the time of the current study, there were no
other health centres within a radius of 10 km from Bozi.
Data collection
In February 2010, a total of 100 malaria RDTs (ICT
ML01 Malaria Pf test; ICT Diagnostics, Cape Town,
South Africa) were made available to the Bozi health
centre by the research team. Medical staff was trained to
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offered to perform an RDT for malaria free of charge to
those patients who presented with fever (i.e. axillary
temperature >37.5°C). Using lay terms, patients were
explained the opportunity to have a finger-prick blood
sample subjected to an RDT for malaria in order to pre-
scribe appropriate medication. Patients without fever
and those living outside Bozi and Yoho were not eligible
for enrolment.
Within two months, a total of 100 people who met our
inclusion criteria were offered an RDT for malaria, but not
all of them were willing to have an RDT performed. In
April 2010, one of the authors (CCC), accompanied by a
key informant from Bozi, conducted a cross-sectional sur-
vey. The objective was to identify and visit all the 100
people in their homes and to interview them with a pre-
tested questionnaire. The questionnaire addressed five
main themes: (i) characterization of the person who was
offered an RDT (e.g. demographic features, educational at-
tainment, religion, etc.); (ii) knowledge, attitudes and prac-
tices of malaria therapy; (iii) perception of blood and
blood-related diseases; (iv) perception of RDTs for mal-
aria, including reasons for acceptance or refusal to have
the test performed; and (v) socio-cultural ideologies
related to RDTs.
Additionally, health care providers (nurse and midwife),
traditional healers and religious leaders were interviewed
to gather specific information on patients’ acceptance or
rejections of RDTs. Interviews with medical staff aimed at
identifying barriers of using RDTs, which were further
investigated in a series of in-depth interviews with the re-
spective patients. Questions addressed to a traditional
healer were focused on patients’ treatment and the im-
portance of taking a blood sample for the diagnosis prior
to prescribing an antimalarial drug. Religious leaders were
interviewed for their opinions of their congregations about
treatment and acceptance of modern health care provided
at health care facilities. Particular emphasis was placed on
the rules and arguments forwarded by religious leaders
that forbid the use of blood for medical examination. The
questionnaire and topic guides (in French) are available
from the authors upon request.
Data analysis
Analyses were performed using R software version
2.10.1 (the R Foundation for Statistical Computing,
2009). Generalized linear mixed models were utilized to
calculate odds ratios (ORs). Response variables were the
acceptance of malaria RDTs that was offered free of
charge during initial health seeking (first use) and ac-
ceptance to have an RDT performed once again if
deemed necessary in the future (further use). Data were
categorical (yes or no). We developed two separate mod-
els: (i) for “first use” and (ii) “further use”. The modelsused fixed effects that were selected among parameters
identified through our questionnaire survey, using a
backward elimination approach, removing variables with
a P value <0.2, one at a time. Village was included in the
models as random effect. To compare groups, χ2 test or
Fisher’s exact test, as appropriate, were employed. ORs
were used to express statistical difference, including 95%
confidence intervals (CIs).
Qualitative data were gathered along the two main
themes “belief” and “medical examination” in connection
with RDTs for malaria. Each theme was addressed
according to specific topics (e.g. blood, malaria, effect-
iveness and usefulness). Once data were categorized and
coded in an Excel spreadsheet, the major trends and pat-
terns were identified. More detailed descriptions, as
articulated by the respondents (freely translated from
French to English), were extracted to underscore and/or
complement the quantitative results.
Results
Determinants for accepting or rejecting RDTs for malaria
From the 100 people interviewed, only 34 were willing to
have an RDT done for malaria. As shown in Table 1, the
proportion of people who were unwilling to accept an
RDT for malaria was very high in Bozi (78.6%), but consid-
erably lower in Yoho (36.7%) (χ2 = 14.62, p <0.001). The
proportion of males who were willing to undergo an RDT
was higher than that of females (39.3% vs. 25.6%). Patients
in the age range of ≥42 years showed a higher willingness
to undergo an RDT for malaria than their younger coun-
terparts (45.4% vs. 30.0-33.3%). Married people (75.0%)
were more likely to accept an RDT for malaria than singles
(25.6%). Households with 1–3 children were more in
favour of an RDT for malaria than smaller or larger house-
holds (exception: very large households with 7-9 children).
Different religious groups showed important differences
with regard to the acceptance of having an RDT per-
formed. While a relatively high proportion of animists and
Muslims were favourable to an RDT for malaria (42.1%
and 40.4%, respectively), a considerably lower percentage
was found for Christians (15.0%). Our population samples
from the two villages showed no statistical difference with
regard to sex, age, marital status, number of children and
religious beliefs. However, willingness to have an RDT for
malaria performed was positively correlated with the level
of education.
Local perception of blood and blood-related diseases
As shown in Table 2, 54% of people perceived blood as a
sacred body fluid and the majority of them were unwill-
ing to have an RDT for malaria performed (55.6%) (χ2 =
4.74, p = 0.029). More than half of the people who think
that blood keeps life in the body (55.6%) were in favour
of an RDT for malaria. Most of the respondents who
Table 1 Characteristics of the study population, stratified
by whether or not people were willing to have an RDT
for malaria performed
Characteristics Number of people interviewed (%) χ2 p
Total Willing to
have an RDT
for malaria
performed
(n=34)
Unwilling to
have an RDT
for malaria
performed
(n=66)
Village
Bozi 70 (70.0) 15 (21.4) 55 (78.6)
Yoho 30 (30.0) 19 (63.3) 11 (36.7) 14.62 <0.001
Sex
Male 61 (61.0) 24 (39.3) 37 (60.7)
Female 39 (39.0) 10 (25.6) 29 (74.4) 1.43 0.232
Age group (years)
14-24 20 (20.0) 6 (30.0) 14 (70.0)
25-41 69 (69.0) 23 (33.3) 46 (66.7)
≥42 11 (11.0) 5 (45.4) 6 (54.5) 0.80 0.670
Marital status
Single 39 (39.8) 10 (25.6) 29 (74.4)
Married 4 (4.0) 3 (75.0) 1 (25.0)
Free union 57 (58.0) 21 (36.8) 36 (63.2) † 0.088
Number of children
0 27 (27.0) 8 (29.6) 19 (70.4)
1-3 47 (47.0) 19 (40.4) 28 (59.6)
4-6 21 (21.0) 5 (23.8) 16 (76.2)
7-9 3 (3.0) 2 (66.7) 1 (33.3)
≥10 2 (2.0) 0 (0) 2 (100) † 0.370
Educational level
Illiterate 42 (42.0) 12 (28.6) 30 (71.4)
Primary 40 (40.0) 13 (32.5) 27 (67.5)
Secondary 14 (14.0) 5 (35.7) 9 (64.3)
Higher
education
4 (4.0) 4 (100) 0 (0) † 0.050
Religious belief
Muslim 52 (52.0) 21 (40.4) 31 (59.6)
Christian 20 (20.0) 3 (15.0) 17 (85.0)
Animist 19 (19.0) 8 (42.1) 11 (57.9)
No religion 9 (9.0) 2 (22.2) 7 (77.8) † 0.154
† Fisher’s exact test.
Table 2 Percentage of local perception of blood and
blood-related diseases, stratified by people’s willingness
or unwillingness of using an RDT for malaria
Local perception
of blood
n (%) χ2 p
Total Willing
(n=34)
Unwilling
(n=66)
Blood is sacred body fluid
Yes 54 (54.0) 24 (44.4) 30 (55.6)
No 46 (46.0) 10 (21.7) 36 (78.3) 4.74 0.029
Blood keeps life in the body
No 91 (91.0) 29 (31.9) 62 (68.1)
Yes 9 (9.0) 5 (55.6) 4 (44.4) † 0.267
Malaria is inside the blood
Yes 44 (44.0) 23 (52.3) 21 (47.7)
No 42 (42.0) 7 (16.7) 35 (83.3)
Don’t know 14 (14.0) 4 (28.6) 10 (71.4) † 0.002
Know about malaria
Don’t know 51 (51.0) 15 (29.4) 36 (70.6)
Symptoms 38 (38.0) 10 (26.3) 28 (73.7)
Malaria test 11 (11.0) 9 (81.8) 2 (18.2) † 0.002
Custom allows blood test
Yes 86 (86.0) 29 (33.7) 57 (66.3)
No 11 (11.0) 4 (36.4) 7 (63.6)
Don’t know 3 (3.0) 1 (33.3) 2 (66.7) † 1.000
Religion allows blood test
Yes 77 (77.0) 26 (33.8) 51 (66.2)
Don’t know 13 (13.0) 4 (30.8) 9 (69.2)
No 10 (10.0) 4 (40.0) 6 (60.0) † 0.873
Reason to have a blood examination performed or not
Care 50 (50.0) 22 (44.0) 28 (56.0)
HIV test 34 (34.0) 4 (11.8) 30 (88.2)
Fate of blood after test 8 (8.0) 2 (25.0) 6 (75.0)
No problem 7 (7.0) 6 (85.7) 1 (14.3) † <0.001
Need to do blood test for a patient
Depends on disease 59 (59.0) 14 (23.7) 45 (76.3)
Yes 19 (19.0) 16 (84.2) 3 (15.8)
No 13 (13.0) 3 (23.1) 10 (76.9)
Don’t know 8 (8.0) 1 (12.5) 7 (87.5) † <0.001
Need to do blood test for malaria patient
No 65 (65.0) 6 (9.2) 59 (90.8)
Yes 33 (33.0) 28 (84.8) 5 (15.2)
Don’t know 2 (2.0) 0 (0) 2 (100) † <0.001
Justification to do blood testing by suspected malaria patients
Know malaria 65 (65.0) 6 (9.2) 59 (90.8)
Don’t know 34 (34.0) 28 (86.4) 6 (13.6)
Treated without test 1 (1.0) 0 (0) 1 (100) † <0.002
† Fisher’s exact test.
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stated that malaria is not in their blood, compared to
16.7% of those who were in favour of an RDT (Fisher’s
exact test, p = 0.002). The concurrent availability and
use of RDTs for HIV and malaria at the same health fa-
cility was associated with an unwilling attitude towards
RDTs for malaria (88.2%) (Fisher’s exact test, p <0.001).
For patients opposed to an RDT for malaria, their
Table 3 Response percentage of local beliefs of RDTs for
malaria, stratified by RDTs acceptance
RDTs representation n (%) χ2 p
Total Willing
(n=34)
Unwilling
(n=66)
Opinions on RDTs
Useful 42 (42.0) 8 (19.0) 34 (81.0)
Dangerous 25 (25.0) 2 (8.0) 23 (92.0)
Not useful 22 (22.0) 19 (86.4) 3 (13.6)
Good 6 (6.0) 5 (83.3) 1 (16.7)
Not good 5 (5.0) 0 (0) 5 (100) † <0.001
RDT utility
No 67 (67.0) 10 (14.9) 57 (85.1)
Yes 33 (33.0) 24 (72.7) 9 (27.3) 30.39 <0.001
Reason to have a blood test made
Don’t know 39 (39.0) 2 (5.1) 37 (94.9)
Feeling unwell 36 (36.0) 8 (22.2) 28 (77.8)
Free of charge 25 (25.0) 24 (96.0) 1 (4.0) † <0.001
Fear of malaria test
Test results 45 (45.0) 18 (40.0) 27 (60.0)
Needle 28 (28.0) 4 (14.3) 24 (85.7)
No fear 27 (27.0) 13 (48.1) 14 (51.9) † 0.023
Reason for whether or not to repeat a malaria test
Fear 39 (39.0) 3 (7.7) 36 (92.3)
Accuracy of test 19 (19.0) 4 (21.1) 15 (78.9)
Painful 17 (17.0) 9 (52.9) 8 (47.1)
Don't know 17 (17.0) 17 (100) 0 (0)
HIV status 8 (8.0) 1 (12.5) 7 (87.5) † <0.001
Knowledge about HIV
Yes 98 (98.0) 33 (33.7) 65 (66.3)
No 2 (2.0) 1 (50.0) 1 (50.0) † 1.000
Reason for whether or not to do an HIV test
Fear 63 (63.0) 13 (20.6) 50 (79.4)
Curiosity 37 (37.0) 21 (56.8) 16 (43.2) † <0.001
HIV test rather than malaria test
Yes 67 (67.0) 19 (28.4) 48 (71.6)
Don't know 27 (27.0) 12 (44.4) 15 (55.6)
No 6 (6.0) 3 (50.0) 3 (50.0) † 0.250
Blood is used for something else
Don’t know 35 (35.0) 11 (31.4) 24 (68.6)
Yes 43 (43.0) 13 (30.2) 30 (69.8)
No 12 (12.0) 5 (41.7) 7 (58.3)
Witchcraft 10 (10.0) 5 (50.0) 5 (50.0) 1.83 0.608
† Fisher’s exact test.
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depends on the disease (76.3%). Most of the patients
who sought care at the health facility, and who were pre-
sumptively diagnosed for malaria, were willing to have
an RDT for malaria done (84.8%).
In general two distinct types of malaria were men-
tioned. First, palu garçon (“male malaria”). In the local
Baoulé language the term for this type of malaria is djè
kouadjo yafua or palu rouge (“red malaria”, with refer-
ence to jaundice), and the local Yowèrè language uses
the term djé kouadjo clonmon. Both expressions are
associated with the harshness related to complicated and
more severe manifestations of malaria. Second, palu
femme (“female malaria”) or palu blanc (“white malaria”)
refers to uncomplicated milder forms of malaria. Local
terms for these types of malaria are djè kouadjo (Baoulé)
and djé kouadio limon (Yowèrè).
These results must be seen against the background of
the common local concept that considers modern medi-
cine as treating only the body, whereas traditional medi-
cine addresses occult origins of a disease without
resorting to the blood. As expressed by a traditional
healer: “when patients agree, I consult the spirits to en-
lighten me on the origin of evil before advising the plants
to be used to treat the disease. I don’t use the blood of
patients for their care even when it is palu garçon”.
Local beliefs of RDTs for malaria
Table 3 summarises local perceptions on RDTs for mal-
aria. Fear was the main reason (92.3%) to avoid repeating
an RDT (Fisher’s exact test, p <0.001). This fear was
linked to the needle and the pain it causes when pene-
trating the human skin (85.7%) and the RDT test result
(60.0%) (Fisher’s exact test, p = 0.023). In addition,
87.5% of patients who declined to have an RDT done for
malaria did not know their HIV status, while 12.5% who
accepted an RDT had already been tested for HIV or
were not afraid of knowing their HIV status.
Traditional treatments are in line with people’s cus-
toms and beliefs, as underscored by the following quote:
“Hospital cannot cure palu garçon (jaundice). If you have
malaria and use a serum you die. Because we don’t know
if malaria is a male or a female, thus giving first prefer-
ence in consulting traditional doctors”. Many of the
respondents found RDTs for malaria of no use. Indeed,
they expressed their opinions by saying: “We know this
disease very well, we have been several times victim of it.
We do not need to be tested” (male respondent, 40-year-
old). Or, as expressed by another study participant in the
unwilling group: “People must have malaria and hemor-
rhoids in their body at any time. We are routinely
exposed to the sun so when we are sick, we know that it
is malaria. We do not need your malaria test” (male,
aged 45 years).
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dents were aware of the non-specificity of some malaria
symptoms, as revealed by the following argument:
“When you have stomach ulcers, you feel as if you have
early malaria. If this test helps to pay cheaper drugs be-
cause we do not have malaria, it is a good deal” (35-
year-old female respondent).
Acceptance of having an RDT done for malaria
The willingness of patients to accept an RDT for malaria
was significantly related to felt fears (first use: OR =
0.001, 95% CI = 0–0.12; further use: OR = 0.007, 95%
CI = 0–0.40) and the desire to know if they really
had malaria (first use: OR = 0.004, 95% CI = 0–0.22;
further use: OR = 0.005, 95% CI = 0–0.30) (Table 4).
The acceptance of having an RDTs for malaria per-
formed at the first time, was not associated with patients
thinking that RDTs are a pretext used by health worker
to know HIV status (OR = 0.48, 95% CI = 0–51.9) asTable 4 Generalized linear mixed model results (outcome:
RDT acceptance; fixed effects: parameters; random
effects: village)
Accept malaria
diagnosis with
an RDT
(first use)
Accept malaria
diagnosis with
an RDT
(further use)
Parameters OR (95% CI) OR (95% CI)
Blood is sacred body fluid 0.47 (0.01-17.5) 0.42 (0.12-1.52)
Blood keeps life in the body 3.61 (0.15-86.3) 7.16 (0.48-107.7)
Malaria is inside the blood
Yes 0.89 (0.07-11.0) 2.55 (0.63-10.3)
Don’t know 0.53 (0.01-23.1) 1.07 (0.18-6.40)
Blood sample for medical test 5.30 (0.37-75.3) 8.31 (2.22-31.1)*
Utility of an RDT 3.64 (0.28-47.5) 0.18 (0.03-1.13)
Reason to have (or not) a malaria test done
Free of charge 1.00 1.00
Fear 0.001 (0–0.12) 0.007 (0–0.40)*
Know HIV status 0.004 (0–0.22) 0.005 (0–0.30)*
Knowledge about HIV
HIV test knowledge 6.28 (0.09-432.9) 1.70 (0.30-9.51)
HIV testing 0.31 (0.02-5.32) 0.61 (0.15-2.59)
Reason to have (or not) an HIV test done
Fear 1.00 1.00
Curiosity 7.79 (0.11-534.6) 20.72 (0.55-781.1)
Difference between malaria
and HIV test
0.22 (0–10.2) 0.16 (0.02-1.09)
HIV test rather than malaria test
Yes 0.48 (0–51.9) 16.61 (1.03-268.5)*
Don’t know 0.89 (0.01-90.9) 1.88 (0.13-26.4)
CI: confidence interval, OR: odds ratio, *statistically significant difference (95%
CI does not include OR of 1.00).well as those thinking that blood samples were necessary
for medical diagnoses and other illness-related issues
(OR = 5.30, 95% CI = 0.37-75.3). However, if asked
whether they were willing to undertake further RDTs
in future, a strong relationship was observed between
acceptance and the idea that RDTs is a pretext used
by health worker to know HIV status (OR = 16.61,
95% CI = 1.03-268.5). Those thinking that obtaining a
blood sample was useful to diagnose for specific dis-
eases through medical examination had an odds of
8.31 (95% CI: 2.22-31.1) to be ready to undergo an
RDT for malaria in future compared to their counter-
parts with an opposed thinking.
Discussion
ACTs have become the first-line treatment and the
large-scale use is assured by the support of the Global
Fund to Fight AIDS, Tuberculosis and Malaria (Global
Fund in short), which has led to a much higher use in
most endemic areas over the past decade despite the
relatively high costs of these drugs. Inaccurate and/or
delayed diagnosis led to an overconsumption of antimal-
arial that can also contribute to the development and
spread of drug resistance [37]. The introduction of RDTs
significantly reduces these risks [38] and provides a
unique opportunity to render the approach of prompt
diagnosis and treatment at peripheral level, i.e. the
point-of-care, more effective [38]. Clearly, the use of
RDT has opened up new ways for adequate case man-
agement. However, acceptance of RDTs still remains an
issue for many endemic areas, as rural populations do
not necessarily agree having their blood tested even for
RDTs for malaria. Currently, little is known about social,
cultural and religious factors governing people’s attitudes
and behaviour that govern acceptance of RDTs.
Our study, undertaken in a rural part of central Côte
d’Ivoire, revealed specific local concepts with regard to
the perception of blood, blood-related diseases and hav-
ing blood tested with an RDT. Interestingly, the majority
of people from Bozi were unwilling to have an RDT for
malaria done that was provided free of charge, but this
was somewhat influenced by educational attainment. In-
deed, unlike Bozi, the majority of household heads in
Yoho had attended at least primary school. Moreover,
the percentage of children from mothers with at least
primary education was higher in Yoho [36]. According
to our questionnaire survey, people believe that they
know the manifestations of clinical symptoms due to
malaria, and hence they do not see the necessity for an
RDT prior to start with treatment. Patients from Bozi
and Yoho were aware of some of the dangers posed by
malaria. However, based on direct observation by our re-
search team, residents from Bozi largely negated help-
seeking as they perceived the quality of care as low.
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the Bozi health centre, it seems conceivable that they
seek care for only serious conditions. In contrast, free
testing with an RDT for malaria and access to drugs
increased their willingness to do the exams. In addition,
the user-provider interactions are crucial as also
observed in a study in Ghana investigating the relation-
ship between health workers and patients [39]. Malaria
can be easily treated when promptly diagnosed but
owing to people’s perceptions and beliefs, several
barriers still exist as indicated by this and many other
studies. Two key determinants are, first, inappropriate
self-medication with medicinal plants or inappropriate
medicine [40] and, second counterfeit or substandard
medicines as revealed in studies from Nigeria [41-43].
Therapies from health centres and traditional healers
were used together, showing an interest to modern
medicine mixed with more traditional remedies. For the
group of people who were unwilling to have malaria
RDTs done, it was their belief that, traditional healers
provided good and clear diagnosis of the disease. There-
fore, visiting a health centre would mean to have mod-
ern drugs that will speed up their recovery.
There were various opinions from our surveys which
contributed to a deeper understanding of the attitudes
and behaviours of Yoho and Bozi populations with re-
gard to RDTs for malaria. The introduction of RDTs was
clearly affected by the different levels of acceptability
owing to the innovative nature of this diagnostic tool
and its use at different levels of the health care delivery
systems. People linked their reluctance to previous
experiences with blood taking and use. For instance,
blood would also be used for other occult practices such
as bewitching and fetishisms, among others. For people,
blood was considered a sacred biofluid and the source of
life. It cannot be used anyhow except when asked pur-
posely for medical testing. This is the reason why, some
people in the study area were compliant to accept RDTs
for malaria, but not for other diseases. By contrast there
was also another group of people who believed that for a
disease like malaria, there is no need to do a diagnostic
test because the signs were sufficient to confirm the idea
that the disease (especially malaria) “is not in the blood”.
Traditional representations did influence the acceptance
of RDTs for malaria. One of these representations was
the feeling to have the best treatment against malaria.
According to their opinion, the best treatment against
malaria did not require the use of blood unlike malaria
RDTs. Thus, the local concepts of malaria as a disease
do have a considerable influence on malaria manage-
ment [44,45].
Acceptability of RDTs was also governed by the level
of perceived fear. Interviewed persons expressed their
fear based on the pain caused by the needle prick, butalso other fears, particularly that blood samples would
be utilized for checking their HIV status instead of mal-
aria. Indeed, we found a high rate of people who refused
to have an RDT performed for malaria, which might be
explained by the fact that before introducing malaria
RDTs at the health centre of Bozi, RDTs for HIV were
already available. Patients might have been afraid to have
their HIV status revealed, and hence explaining their re-
luctance to undergo an RDT for malaria. Reports from
Tanzania showed that people had the same feeling of
fear towards RDTs. Nevertheless the usage of RDTs was
of little matter when they understood that this test con-
firmed malaria presence and helped to make effective
and right prescription for the most appropriate drugs
leading to cure [46]. Our findings thus emphasize the
importance of information, education and communica-
tion (IEC) readily adapted to the local context.
Some social parameters had no influence on RDTs ac-
ceptance, but played a more subtle role. We noted that
higher education level was a factor of better adherence
to RDTs. In these rural areas those who were educated
seek information from the specialized people as indi-
cated. Thus, they received appropriate responses to their
concerns and questions. Attitudes and behaviour to-
wards RDTs was also partly motivated by the strict ob-
servance of religious prohibitions. These aspects
prevented proper social integration of malaria RDTs to
these rural communities.
In other areas, RDTs for malaria were well accepted by
volunteers from the community. This was the most ap-
propriate way to diagnose asymptomatic cases of malaria
[47]. Urban populations were more ready and able to
purchase malaria RDTs, while rural population and the
poorest of the poor preferred RDTs free of charge [28].
In some countries, health workers use RDTs but adher-
ence to the result is low [48-50]. For example, low ad-
herence to RDTs was observed in rural parts of Burkina
Faso because the health workers were more confident to
the usual malaria symptoms from their experience than
any new malaria test, which sometimes challenged their
classical diagnosis [51] or it could be related to their in-
ability to better perform and interpret results from the
test [39].
Our study has some limitations. First, we pursued a
convenience sampling and the size of our sample is rela-
tively small (i.e. 100 RDTs for malaria were provided free
of charge to a single health centre and a total of 100
people were interviewed). Second, within two months
100 individuals seeking care at the Bozi health centre
met our inclusion criteria (i.e. axillary temperature
>37.5°C), and hence were offered an RDT for malaria,
but only about a third were willing to perform the rapid
test. Due to time and budget constraints, we were unable
to run the study until all 100 RDTs had been utilized.
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ried out two months after the introduction of RDTs for
malaria, which might have introduced some recall bias.
Finally, based on a single health centre and some obser-
vations that patients were no entirely satisfied with the
overall quality of the service, it is difficult to generalize
our findings. Clearly, our study was designed as an ex-
ploratory piece, and hence larger-scale studies should be
undertaken to assess the full validity of the findings
reported here.
Conclusions
The present work addressed some of the social and cul-
tural dimensions of introducing RDTs for malaria, which
is essential for prompt diagnosis and adequate treat-
ment. Acceptability is governed by socio-cultural and
political factors, which need to be taken into account
when tailoring integrated malaria control or elimination
to a specific setting. The parallel use of RDTs for HIV
and malaria calls for specific action and messages in the
programmes to sensitize communities so that the two
crucial point-of-care tests remain effective tools. Major
challenges in the field (e.g. locally adapted IEC strat-
egies) are ahead of us if we really coherently embark on
an integrated malaria control that will eventually lead to
malaria elimination/eradication.
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